ArticleBMC immunology2025
Single-cell RNA sequencing reveals immune cell dysfunction and rewired interaction networks in the peripheral blood of active tuberculosis patients.
Article in BMC immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Tuberculosis (TB), caused by Mycobacterium tuberculosis (Mtb), remains a global health threat with poorly understood immune mechanisms. This exploratory study employed single-cell RNA sequencing (scRNA-seq) on peripheral blood mononuclear cells (PBMCs) from 3 active TB (ATB) patients and 2 healthy controls (HC) to dissect immune cell dysfunction and communication networks. Data were processed using CellRanger, Seurat, and Harmony for quality control, batch correction, and clustering, with cell types annotated via marker genes and SingleR. Functional analyses included cytotoxicity, antigen presentation scoring, differential gene expression, and Gene Ontology (GO) enrichment, while CellChat mapped ligand-receptor interactions. Results revealed altered immune cell composition in ATB, including increased myeloid cells/platelets and reduced NK cells. CD8 + effector T cells (CD8_Te) and CD16bright CD56dim NK cells (NK_CD56dim) exhibited reduced expression of cytotoxicity-associated genes, while Naïve B cells (Naïve_B)and dendritic cells(DC) showed impaired antigen presentation. RNA metabolism pathways were upregulated alongside suppressed immune regulation. Cell communication analysis identified weakened CD8 + T cell incoming signals, enhanced B/NK cell signaling, and intensified monocyte-driven interactions. TGF-β pathway enrichment and defective MHC signaling disrupted network dynamics, suggesting RNA metabolism dysregulation and TGF-β-mediated immunosuppression as key mechanisms. These findings provide insights that may help inform future studies on TB immunopathology and treatment development. Limitations include reliance on peripheral blood, small sample size, and lack of protein-level validation. Future studies should integrate multi-omics and functional assays to validate these pathways.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.